"Blockers" can benefit from 300IR house dust mite tablet-results of a large multicentre clinical trial in house dust mite induced allergic rhinitis patients
Pascal Demoly, Peter S. Creticos, F. de Blay, Philippe Gevaert, Krzysztof Kowal, M. Le Gall, Natalia Nenasheva, G. Passalacqua, Oliver Pfaar, Miguel Tortajada‐Girbés, Christopher Vidal, Thomas B. Casale, Jonathan Corren
Abstract